Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration Into the Association Between Decorin (DCN) Expression and MR Phenotypes in GBM

NCT06090903 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT06090903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06090903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration Into the Association Between Decorin (DCN) Expression and MR Phenotypes in GBM
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
April 14, 2022
Completion date
April 18, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, recurrent glioblastoma, resectable glioblastoma